| <img alt="" height="1" width="1" />SYNERGY PHARMACEUTICALS INITIATES PHASE IIA CLINICAL TRIALTrading Markets (press release)SP-304 is a member of a new class of non-systemic drugs for treatment of chronic constipation (CC), irritable bowel syndrome with constipation (IBS-C) and ...<nobr></nobr> |
Google- SYNERGY PHARMACEUTICALS INITIATES PHASE IIA CLINICAL TRIAL - Trading Markets (press release)
1 - 1 of 1 Posts
1 - 1 of 1 Posts
- This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Join the discussion
Irritable Bowel Syndrome and Digestive Health Support Forum
A forum community dedicated to Irritable Bowel Syndrome and Digestive Health Support. Come join the discussion about treatment, diet, health, lifestyles, spirituality, medication, research, recovery, and more!
Full Forum Listing
Recommended Communities
Join now to ask and comment!